- |
Overall (n = 1,400) |
Readmission group (n = 113) |
Non-readmission group (n = 1,287) |
P-value |
Demographic data |
|
|
|
|
Age (years), median (IQR) |
68 (56-76) |
70 (59-77) |
68 (56-76) |
0.318 |
Male, n (%) |
836 (59.7) |
74 (65.5) |
762 (59.2) |
0.238 |
Clinical characteristics |
|
|
|
|
Charlson Comorbidity Index, median (IQR) |
5 (3-6) |
5 (3-7) |
5 (3-6) |
0.460 |
APACHE II, median (IQR) |
18 (15-22) |
19 (16-23) |
18 (15-21) |
0.002 |
SOFA at ICU admission, median (IQR) |
6 (4-8) |
7 (5-10) |
6 (4-8) |
<0.001 |
ICU length of stay (days), median (IQR) |
3 (2-6) |
4 (2-8) |
3 (2-6) |
0.002 |
Mortality for 28 days |
65 (4.6) |
11 (9.7) |
54 (4.2) |
0.014 |
ICU admission source |
Medical, n (%) |
797 (56.9) |
79 (69.9) |
718 (55.8) |
0.005 |
Surgical, n (%) |
603 (43.1) |
34 (30.1) |
569 (54.2) |
0.005 |
Reasons for ICU admission |
Sepsis, n (%) |
256 (18.3) |
28 (24.8) |
228 (17.2) |
0.082 |
Cardiovascular surgery, n (%) |
195 (13.9) |
13 (11.5) |
182 (14.1) |
0.526 |
Other surgery, n (%) |
405 (28.9) |
21 (18.6) |
384 (29.8) |
0.015 |
Respiratory failure, n (%) |
220 (15.7) |
29 (25.7) |
191 (14.8) |
0.004 |
Circulatory failure, n (%) |
145 (10.4) |
11 (9.7) |
134 (10.4) |
0.948 |
Cerebrovascular disease, n (%) |
24 (1.7) |
1 (0.9) |
23 (1.8) |
0.741 |
Acute kidney injury, n (%) |
59 (4.2) |
1 (0.9) |
58 (4.5) |
0.111 |
Acute pancreatitis, n (%) |
31 (2.2) |
4 (3.5) |
27 (2.1) |
0.506 |
Endocrine disease, n (%) |
67 (4.8) |
3 (2.7) |
64 (5.0) |
0.381 |
Liver failure, n (%) |
27 (1.9) |
5 (4.4) |
22 (1.7) |
0.097 |
Metabolic disorder, n (%) |
16 (1.1) |
1 (0.9) |
15 (1.2) |
1.000 |
Treatment variables of the group |
Mechanical ventilation, n (%) |
757 (54.1) |
65 (57.5) |
692 (53.8) |
0.503 |
Ventilator days, median (IQR) |
1.0 (0-3.0) |
2.0 (0-5.3) |
1.0 (0-3.0) |
0.006 |
CKRT, n (%) |
253 (18.1) |
36 (31.9) |
217 (16.9) |
<0.001 |
PMX-DHP, n (%) |
74 (5.3) |
10 (8.8) |
64 (5.0) |
0.122 |
IABP, n (%) |
30 (2.1) |
0 (0) |
30 (2.3) |
0.193 |
Impella®️, n (%) |
7 (0.5) |
1 (0.9) |
6 (0.5) |
1.000 |
Tracheal suctioning, n (%) |
184 (13.1) |
30 (26.5) |
154 (12.0) |
<0.001 |
Use of catecholamine, n (%) |
51 (3.6) |
5 (4.4) |
46 (3.5) |
0.841 |
Low-flow oxygen therapy, n (%) |
946 (67.6) |
82 (72.6) |
864 (67.1) |
0.281 |
HFNC, n (%) |
86 (6.1) |
3 (2.7) |
83 (6.5) |
0.160 |
Parameters at ICU discharge |
SBP (mmHg), median (IQR) |
121 (108-135) |
123 (108-139) |
121 (108-135) |
0.457 |
DBP (mmHg), median (IQR) |
69 (60-79) |
69 (60-83) |
69 (60-78) |
0.906 |
HR (bpm), median (IQR) |
83 (72-96) |
89 (80-102) |
82 (72-95) |
<0.001 |
BT (℃), median (IQR) |
37.0 (37.0-37.8) |
37.2 (37.0-38.0) |
37.0 (36.9-37.7) |
0.006 |
RR (bpm), median (IQR) |
19 (16-22) |
21 (17-25) |
19 (16-22) |
<0.001 |
SpO2 (%), median (IQR) |
98 (96-99) |
97 (96-98) |
98 (96-99) |
0.003 |
GCS, median (IQR) |
15 (14-15) |
14 (12-15) |
15 (14-15) |
<0.001 |
Cold extremities, n (%) |
124 (8.9) |
37 (32.7) |
87 (6.8) |
<0.001 |
P/F, median (IQR) |
357 (269-438) |
333 (238-397) |
358 (274-443) |
0.004 |
PaCO2 (mmHg), median (IQR) |
37.0 (34.0-41.0) |
36.0 (34.2-41.3) |
37.0 (34.0-41.0) |
0.514 |
pH, median (IQR) |
7.43 (7.40-7.47) |
7.44 (7.41-7.48) |
7.43 (7.40-7.47) |
0.059 |
Sleep disturbance, n (%) |
265 (18.9) |
72 (63.7) |
193 (15.0) |
<0.001 |
Delirium, n (%) |
116 (8.3) |
11 (9.7) |
91 (7.1) |
0.342 |
Reason for ICU readmission |
Respiratory failure, n (%) |
- |
46 (40.7) |
- |
- |
Circulatory failure, n (%) |
- |
35 (31.0) |
- |
- |
Renal failure, n (%) |
- |
13 (11.5) |
- |
- |
Electrolyte disturbances, n (%) |
- |
10 (8.8) |
- |
- |
Neurological failure, n (%) |
- |
9 (8.0) |
- |
- |